HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Introduces Nervive ‘Nerve Relief’ Supplements In US, Extending Line Acquired From Merck

Executive Summary

P&G launches Nervive three-product line for nerve discomfort inspired by 50-year-old Neurobion brand marketed in Europe, Asia and Latin America. The products contain B-complex vitamins and alpha lipoic acid to promote blood flow.

You may also be interested in...



US Q2 Consumer Health Earnings Preview: Will More Favorable Year-Ago Comparisons Help?

April-June sales of OTC drugs, supplements and personal care products likely will show at least notable and potentially strong increases from year-ago period when consumers slowed spending after splurging during 2020 Q1 as novel coronavirus pandemic sent shockwaves through the marketplace.

Neuropathy Treatment Group's Supplement Claims Strike A Nerve In Industry Self-Regulation Review

Neuropathy Treatment Group continues to make on its website numerous references to neuropathy and other diseases or conditions causing nerve pain. It pulled most of its challenged claims during a NAD review, and was advised to discontinue the remainder, too.

P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty

P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS151487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel